Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,940 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.
De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Saliba F, Jonas S, Sudan D, Fung J, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Witte S, Jiang H, Hexham JM, Junge G; H2304 Study Group. De Simone P, et al. Among authors: jiang h. Am J Transplant. 2012 Nov;12(11):3008-20. doi: 10.1111/j.1600-6143.2012.04212.x. Epub 2012 Aug 6. Am J Transplant. 2012. PMID: 22882750 Free PMC article. Clinical Trial.
Randomized, Open-Label, Phase IV, Korean Study of Kidney Transplant Patients Converting From Cyclosporine to Prolonged-Release Tacrolimus Plus Standard- or Reduced-Dose Corticosteroids.
Baek CH, Kim CD, Lee DR, Kim YH, Yang J, Kim BS, Lee JS, Han SY, Kim SW, Lee S, Lee KW, Kong JM, Shin BC, Lee SH, Chae DW, Kwon YJ, Jiang H, Lee H, Park SK. Baek CH, et al. Among authors: jiang h. Transplant Proc. 2019 Apr;51(3):749-760. doi: 10.1016/j.transproceed.2019.01.057. Epub 2019 Jan 26. Transplant Proc. 2019. PMID: 30979460 Free article. Clinical Trial.
Once-daily, prolonged-release tacrolimus vs twice-daily, immediate-release tacrolimus in de novo living-donor liver transplantation: A Phase 4, randomized, open-label, comparative, single-center study.
Shin MH, Song GW, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Ha TY, Jung DH, Park GC, Yun YI, Kim WJ, Kang WH, Kim SH, Jiang H, Lee S, Tak EY. Shin MH, et al. Among authors: jiang h. Clin Transplant. 2018 Sep;32(9):e13376. doi: 10.1111/ctr.13376. Epub 2018 Aug 26. Clin Transplant. 2018. PMID: 30098071 Clinical Trial.
Efficacy and safety of prolonged-release versus immediate-release tacrolimus in de novo liver transplant recipients in South Korea: a randomized open-label phase 4 study (MAPLE).
Kim MS, Joh JW, Kim DS, Kim SH, Choi JS, Lee J, Lee JY, Kim JM, Kwon CHD, Choi GS, Yu YD, Yoon YI, Han JH, Lee YJ, Jiang H, Kim SI. Kim MS, et al. Among authors: jiang h. Korean J Transplant. 2019 Jun 30;33(2):20-29. doi: 10.4285/jkstn.2019.33.2.20. Korean J Transplant. 2019. PMID: 35769149 Free PMC article.
Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults.
Chin HJ, Chae DW, Kim YC, An WS, Ihm C, Jin DC, Kim SG, Kim YL, Kim YS, Kim YG, Koo HS, Lee JE, Lee KW, Oh J, Park JH, Jiang H, Lee H, Lee SK. Chin HJ, et al. Among authors: jiang h. J Am Soc Nephrol. 2021 Jan;32(1):199-210. doi: 10.1681/ASN.2019050546. Epub 2020 Nov 9. J Am Soc Nephrol. 2021. PMID: 33168602 Free PMC article. Clinical Trial.
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF, Ferreira U, Efstathiou E, Madziarska K, Kolinsky MP, Cubero DIG, Noerby B, Zohren F, Lin X, Modelska K, Sugg J, Steinberg J, Hussain M; PROSPER Investigators. Sternberg CN, et al. N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469184 Clinical Trial.
28,940 results
You have reached the last available page of results. Please see the User Guide for more information.